Literature DB >> 33285302

Hepatokines and Metabolism: Deciphering Communication from the Liver.

Sharon O Jensen-Cody1, Matthew J Potthoff2.   

Abstract

The liver is a key regulator of systemic energy homeostasis and can sense and respond to nutrient excess and deficiency through crosstalk with multiple tissues. Regulation of systemic energy homeostasis by the liver is mediated in part through regulation of glucose and lipid metabolism. Dysregulation of either process may result in metabolic dysfunction and contribute to the development of insulin resistance or fatty liver disease. The liver has also recently been recognized as an endocrine organ that secretes hepatokines, which are liver-derived factors that can signal to and communicate with distant tissues. Dysregulation of liver-centered inter-organ pathways may contribute to improper regulation of energy homeostasis and ultimately, metabolic dysfunction. Deciphering the mechanisms that regulate hepatokine expression and communication with distant tissues is essential for understanding inter-organ communication as well as for the development of therapeutic strategies for metabolic dysfunction. In this review, we highlight key hepatokines and their role in metabolic control. We also examine the molecular mechanisms of each hepatokine and discuss their potential as therapeutic targets for metabolic disease. Published by Elsevier GmbH.

Entities:  

Keywords:  glucose homeostasis; hepatokine; insulin sensitivity; liver; nutrient; obesity

Year:  2020        PMID: 33285302     DOI: 10.1016/j.molmet.2020.101138

Source DB:  PubMed          Journal:  Mol Metab        ISSN: 2212-8778            Impact factor:   7.422


  21 in total

1.  FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism.

Authors:  Ewa Szczepańska; Piotr Glinicki; Wojciech Zgliczyński; Jadwiga Słowińska-Srzednicka; Helena Jastrzębska; Małgorzata Gietka-Czernel
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

2.  Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study.

Authors:  Pomme I H G Simons; Olivier Valkenburg; Marjo P H van de Waarenburg; Marleen M J van Greevenbroek; M Eline Kooi; Jacobus F A Jansen; Casper G Schalkwijk; Coen D A Stehouwer; Martijn C G J Brouwers
Journal:  Diabetologia       Date:  2022-09-17       Impact factor: 10.460

Review 3.  In vitro skeletal muscle models for type 2 diabetes.

Authors:  Christina Y Sheng; Young Hoon Son; Jeongin Jang; Sung-Jin Park
Journal:  Biophys Rev (Melville)       Date:  2022-09-13

4.  Transcriptome Analysis of Multiple Metabolic Tissues in High-Salt Diet-Fed Mice.

Authors:  Fei Mao; E Wang; Jing Xu; Jin Lu; Guofeng Yan; Li Fu; Yang Jiao; Ling Wu; Tiemin Liu; Yao Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-17       Impact factor: 6.055

Review 5.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

6.  Muscle atrophy phenotype gene expression during spaceflight is linked to a metabolic crosstalk in both the liver and the muscle in mice.

Authors:  Geraldine Vitry; Rebecca Finch; Gavin Mcstay; Afshin Behesti; Sébastien Déjean; Tricia Larose; Virginia Wotring; Willian Abraham da Silveira
Journal:  iScience       Date:  2022-09-24

Review 7.  Metabolic Messengers: FGF21.

Authors:  Kyle H Flippo; Matthew J Potthoff
Journal:  Nat Metab       Date:  2021-03-18

Review 8.  Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.

Authors:  Xi-Hua Liu; Lian-Wen Qi; Raphael N Alolga; Qun Liu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 9.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

Authors:  Ana Rita de Oliveira Dos Santos; Bárbara de Oliveira Zanuso; Vitor Fernando Bordin Miola; Sandra Maria Barbalho; Patrícia C Santos Bueno; Uri Adrian Prync Flato; Claudia Rucco P Detregiachi; Daniela Vieira Buchaim; Rogério Leone Buchaim; Ricardo José Tofano; Claudemir Gregório Mendes; Viviane Alessandra Capelluppi Tofano; Jesselina F Dos Santos Haber
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

10.  Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study.

Authors:  Nooshin Ghodsian; Eloi Gagnon; Jérôme Bourgault; Émilie Gobeil; Hasanga D Manikpurage; Nicolas Perrot; Arnaud Girard; Patricia L Mitchell; Benoit J Arsenault
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.